Sungsoon Hwang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sungsoon Hwang has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
Sang Jin Kim
3 shared publicationsJa-Hyun Jang
2 shared publicationsJe Moon Yoon
2 shared publications- Mi-Ae Jang
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Sang Jin Kim
Department of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications - Sohee Jeon
Keye Eye Center Seoul Korea
2 shared publications
Latest Publications
- 3 September 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 406-415
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics
- 3 September 2026
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 292, 406-415
USH2A-Associated Retinitis Pigmentosa in Koreans: Molecular Genetics and Clinical Characteristics
- Open Access
- 29 December 2025
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 46 (2) , 200-209
Age-Stratified Genetic Spectrum of Retinitis Pigmentosa in Korean Patients: Predominance of RPGR Variants in Early-Onset Disease
Youn-Ji Hong, M.D., Sungsoon Hwang, M.D., Ph.D., Ja-Hyun Jang, M.D., Ph.D., Jong-Won Kim, M.D., Ph.D., Sang Jin Kim, M.D., Ph.D., and Mi-Ae Jang, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2025.0146
- 29 December 2025
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 46 (2) , 200-209
Open AccessAge-Stratified Genetic Spectrum of Retinitis Pigmentosa in Korean Patients: Predominance of RPGR Variants in Early-Onset Disease
Youn-Ji Hong, M.D., Sungsoon Hwang, M.D., Ph.D., Ja-Hyun Jang, M.D., Ph.D., Jong-Won Kim, M.D., Ph.D., Sang Jin Kim, M.D., Ph.D., and Mi-Ae Jang, M.D., Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2025.0146
- 6 March 2025
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 274, 171-183
Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa: Molecular Genetics and Clinical Characteristics
- 6 March 2025
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 274, 171-183
Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa: Molecular Genetics and Clinical Characteristics
- 28 November 2024
- Published by Elsevier in Ophthalmology Retina
- Vol. 9 (6) , 570-579
Clinical Characteristics and Treatment Outcomes in Unilateral Coats Disease
- 28 November 2024
- Published by Elsevier in Ophthalmology Retina
- Vol. 9 (6) , 570-579
Clinical Characteristics and Treatment Outcomes in Unilateral Coats Disease
- 23 August 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 269, 69-77
COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population
- 23 August 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 269, 69-77
COVID-19 Vaccination and Ocular Adverse Events: A Self-Controlled Case Series Study From the Entire South Korean Population
- Open Access
- 2 May 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (9) , e028027
Age‐Related Macular Degeneration With Visual Disability Is Associated With Cardiovascular Disease Risk in the Korean Nationwide Cohort
Background: Age‐related macular degeneration (AMD) is the leading cause of visual disability. AMD shares some risk factors with the pathogenesis of cardiovascular disease (CVD). However, previous studies examining the association between AMD and the risk of CVD provide conflicting results. Hence, we investigated the association between AMD, visual disability, and the risk of CVD. Methods and Results: This is a nationwide cohort study using data from the Korean National Health Insurance System database (2009–2019) on subjects who underwent a national health screening program in 2009. A total of 3 789 963 subjects were categorized by the presence of AMD and visual disability. Visual disability was defined as a best‐corrected visual acuity of ≤20/100 by validated documentation from a specialist physician. Cox regression hazard model was used to examine the hazard ratios (HRs) of CVD, including myocardial infarction and ischemic stroke, after adjusting for potential confounders. During a mean 9.77 years of follow‐up, AMD was associated with a 5% higher risk of myocardial infarction (adjusted HR [aHR], 1.05 [95% CI, 1.01–1.10]) but not associated with increased risk of overall CVD (aHR, 1.02 [95% CI, 1.00–1.05]) or ischemic stroke (aHR, 1.02 [95% CI, 0.98–1.06]). However, when AMD was accompanied by visual disability, there was increased risk of CVD (aHR, 1.17 [95% CI, 1.06–1.29]), myocardial infarction (aHR, 1.18 [95% CI, 1.01–1.37]), and ischemic stroke (aHR, 1.20 [95% CI, 1.06–1.35]). These trends were more evident in women and subjects with cardiometabolic comorbidities. Conclusions: AMD with visual disability, but not all AMD, was associated with an increased risk of CVD. Patients with AMD who have visual disability should be targeted for CVD prevention.
- 2 May 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (9) , e028027
Open AccessAge‐Related Macular Degeneration With Visual Disability Is Associated With Cardiovascular Disease Risk in the Korean Nationwide Cohort
Background: Age‐related macular degeneration (AMD) is the leading cause of visual disability. AMD shares some risk factors with the pathogenesis of cardiovascular disease (CVD). However, previous studies examining the association between AMD and the risk of CVD provide conflicting results. Hence, we investigated the association between AMD, visual disability, and the risk of CVD. Methods and Results: This is a nationwide cohort study using data from the Korean National Health Insurance System database (2009–2019) on subjects who underwent a national health screening program in 2009. A total of 3 789 963 subjects were categorized by the presence of AMD and visual disability. Visual disability was defined as a best‐corrected visual acuity of ≤20/100 by validated documentation from a specialist physician. Cox regression hazard model was used to examine the hazard ratios (HRs) of CVD, including myocardial infarction and ischemic stroke, after adjusting for potential confounders. During a mean 9.77 years of follow‐up, AMD was associated with a 5% higher risk of myocardial infarction (adjusted HR [aHR], 1.05 [95% CI, 1.01–1.10]) but not associated with increased risk of overall CVD (aHR, 1.02 [95% CI, 1.00–1.05]) or ischemic stroke (aHR, 1.02 [95% CI, 0.98–1.06]). However, when AMD was accompanied by visual disability, there was increased risk of CVD (aHR, 1.17 [95% CI, 1.06–1.29]), myocardial infarction (aHR, 1.18 [95% CI, 1.01–1.37]), and ischemic stroke (aHR, 1.20 [95% CI, 1.06–1.35]). These trends were more evident in women and subjects with cardiometabolic comorbidities. Conclusions: AMD with visual disability, but not all AMD, was associated with an increased risk of CVD. Patients with AMD who have visual disability should be targeted for CVD prevention.
- 1 November 2017
- Published by SLACK, Inc. in Journal of Pediatric Ophthalmology & Strabismus
- Vol. 54 (6) , e67-e70
A Case of Orbital Lipoblastoma: Temporal Evolution of Imaging Findings
Lipoblastoma is a rare tumor that is not commonly seen in the orbit. The authors present clinical features, histopathologic findings, changes in the radiologic findings over time, and the radiological-pathological correlation of orbital lipoblastoma in an infant. A 3-month-old male infant presented with a palpable mass on the left upper eyelid. The patient was observed for 1 year with magnetic resonance imaging. At the age of 15 months, the patient underwent excisional biopsy. Histopathologic examination showed features of hypocellular lobules with a mixture of adipocytes of various stages of maturity and myxoid stroma separated by prominent fibrous septa, confirming a diagnosis of orbital lipoblastoma. [J Pediatr Ophthalmol Strabismus. 2017;54:e67-e70.].
- 1 November 2017
- Published by SLACK, Inc. in Journal of Pediatric Ophthalmology & Strabismus
- Vol. 54 (6) , e67-e70
A Case of Orbital Lipoblastoma: Temporal Evolution of Imaging Findings
Lipoblastoma is a rare tumor that is not commonly seen in the orbit. The authors present clinical features, histopathologic findings, changes in the radiologic findings over time, and the radiological-pathological correlation of orbital lipoblastoma in an infant. A 3-month-old male infant presented with a palpable mass on the left upper eyelid. The patient was observed for 1 year with magnetic resonance imaging. At the age of 15 months, the patient underwent excisional biopsy. Histopathologic examination showed features of hypocellular lobules with a mixture of adipocytes of various stages of maturity and myxoid stroma separated by prominent fibrous septa, confirming a diagnosis of orbital lipoblastoma. [J Pediatr Ophthalmol Strabismus. 2017;54:e67-e70.].